Related Experiment Video
Updated: Jun 16, 2026
07:50
Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
Teleoncology: current and future applications for improving cancer care globally
Ribhi Hazin1, Ibrahim Qaddoumi
1Faculty of Arts and Sciences, Harvard University, Cambridge, MA, USA.
The Lancet. Oncology
|February 16, 2010
Summary
Teleoncology, using medical telecommunications for cancer care, can improve access and quality, especially in underserved regions. Consistent, tailored implementation is key to reducing global cancer care inequality.
Area of Science:
- Oncology
- Medical Informatics
- Global Health
Background:
- Quality cancer care is limited in low-resource settings and remote areas.
- Teleoncology offers a solution to bridge these accessibility gaps.
- Existing teleoncology initiatives show promise in improving cancer care delivery.
Purpose of the Study:
- To review teleoncology initiatives and their potential impact.
- To provide guidelines for developing teleoncology programs in low- and middle-income countries.
- To address cancer care inequality globally.
Main Methods:
- Review of existing teleoncology projects and literature.
- Analysis of teleoncology's role in enhancing cancer care access and quality.
- Development of strategic recommendations for program implementation.
Main Results:
- Teleoncology applications, including remote pathology and radiology, can significantly enhance cancer care.
- Tailored implementation strategies are crucial for success in diverse settings.
- Consistent, long-term application is vital for achieving desired outcomes.
Conclusions:
- Teleoncology has the potential to reduce cancer care disparities between resource-rich and resource-poor institutions.
- Strategic development and implementation are necessary for effective teleoncology programs.
- Further development of teleoncology is essential for global cancer equity.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.